Sickle Cell Disorders: Clinical Trials

2 trials for Sickle Cell Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1

Follow Sickle Cell Disorders: new trials by email Literature Review of Sickle Cell Disorders trials Research Report on Sickle Cell Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Fostamatinib - Sickle Cell Disorders, Sickle Cell Disease
Phase 1RecruitingNational Heart, Lung, and Blood Institute (NHLBI)352024-12-182026-11-05
Safety Study of MP4CO in Adult Sickle Cell Patients
MP4CO, Sodium chloride solution - Anemia, Sickle Cell, Sickle Cell Anemia
Phase 1CompletedSangart322012-01-012013-08-19

Narrower conditions

Anemia, Sickle Cell (2)  ·  Hemoglobin SC Disease (1)  ·  Sickle Cell Trait (1)  ·  Vaso-Occlusive Crises (1)

Broader conditions

Anemia (2)  ·  Anemia, Hemolytic (2)  ·  Anemia, Hemolytic, Congenital (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemoglobinopathies (2)

Interventions

PEGylated carboxyhemoglobin bovine (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  fostamatinib (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Sangart (1)

Countries

France (1)  ·  Jamaica (1)  ·  Lebanon (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Swee Lay Thein, M.D. (1)  ·  Tania Small, MD (1)